Table 3.
Predicted risk for the average patient in primary and secondary prevention population
| Patient characteristics | Case 1 | Case 2 | ||||
|---|---|---|---|---|---|---|
| Age | 67 | 73 | ||||
| Gender | Female | Male | ||||
| Type of insurance | Medicare, other | Medicare, other | ||||
| Race/ethnicity | White, non-Hispanic | White, non-Hispanic | ||||
| Region | Mid-West | South | ||||
| Prior CVD diagnoses | None | CHF (≥ 12 months ago), Other CVD-related condition | ||||
| aDCSI | 1 | 3 | ||||
| Diabetes-related hospitalizations | No | No | ||||
| Other recorded diagnoses | Hypertension, hyperlipidemia | Hypertension, hyperlipidemia, infection | ||||
| Predicted riska | MACE (%) | MACE-plus (%) | CVD-related death (%) | MACE (%) | MACE-plus (%) | CVD-related death (%) |
|---|---|---|---|---|---|---|
| At 6 month | 0.7 | 1.1 | 0.2 | 3.2 | 6.1 | 1.3 |
| At 1 year | 1.4 | 2.2 | 0.3 | 5.8 | 10.6 | 2.4 |
| At 2 years | 2.7 | 4.3 | 0.7 | 10.5 | 18.5 | 4.5 |
| At 3 years | 4.1 | 6.4 | 1.0 | 14.4 | 24.3 | 6.4 |
| At 5 years | 6.8 | 10.6 | 1.7 | 21.8 | 35.2 | 9.9 |
aDCSI adapted diabetes complications severity index, CHF congestive heart failure, CVD cardiovascular disease, MACE major adverse cardiovascular event, CI confidence interval
aPredicted risk for a hypothetical patient based on listed characteristics